eCite Digital Repository
Pseudomonas signal molecule 3-oxo-C12-homoserine lactone interferes with binding of rosiglitazone to human PPARγ
Citation
Cooley, MA and Whittall, C and Rolph, MS, Pseudomonas signal molecule 3-oxo-C12-homoserine lactone interferes with binding of rosiglitazone to human PPARγ, Microbes and Infection: A Journal on Infectious Agents and Host Defenses, 12, (3) pp. 231-237. ISSN 1286-4579 (2010) [Refereed Article]
 | PDF Restricted - Request a copy 2Mb |
Copyright Statement
The definitive version is available at http://www.sciencedirect.com
Official URL: http://www.sciencedirect.com
DOI: doi:10.1016/j.micinf.2009.12.009
Abstract
Peroxisome proliferator activated receptor (PPARã) has been suggested as a target for anti-inflammatory therapy in chronic lung disease, including infection with Pseudomonas aeruginosa. However, the P. aeruginosa signal molecule N-(3-oxo-dodecanoyl)-l-homoserine lactone (3-oxo-C12-HSL) has been reported to inhibit function of PPARs in mammalian cells. This suggests that binding of 3-oxo-C12-HSL to PPARs could increase inflammation during P. aeruginosa infection, particularly if it could compete for binding with other PPAR ligands. We investigated the ability of 3-oxo-C12-HSL to bind to a PPARã ligand binding domain (LBD) construct, and to compete for binding with the highly active synthetic PPARã agonist rosiglitazone. We demonstrate that 3-oxo-C12-HSL binds effectively to the PPARã ligand binding domain, and that concentrations of 3-oxo-C12-HSL as low as 1 nM can effectively interfere with the binding of rosiglitazone to the PPARã ligand binding domain. Because 3-oxo-C12 HSL has been demonstrated in lungs during P. aeruginosa infection, blockade of PPARã-dependent signaling by 3-oxo-C12-HSL produced by the infecting P. aeruginosa could exacerbate infection-associated inflammation, and potentially impair the action of PPAR-activating therapy. Thus the proposed use of PPARã agonists as anti-inflammatory therapy in lung P. aeruginosa infection may depend on their ability to counteract the effects of 3-oxo-C12-HSL.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | PPAR; Pseudomonas; Inflammation; Homoserine lactones |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Infectious diseases |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Cooley, MA (Associate Professor Margaret Cooley) |
| ID Code: | 65396 |
| Year Published: | 2010 |
| Web of Science® Times Cited: | 31 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2010-11-10 |
| Last Modified: | 2014-11-25 |
| Downloads: | 1 View Download Statistics |
Repository Staff Only: item control page